Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

31 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-06-30

Study Completion Date

2015-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to evaluate the effect of 3 months of "Snoezelen-type" multi-sensory care sessions on NeuroPsychiatric Inventory Questionnaire (NPI-Q) scores for patients with Alzheimer's-type neurodegenerative disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease.

NCT05709210

Alzheimer Disease Memory Disorders

RECRUITING NA

Dementia Patient's Behavior Evaluation Using Noninvasive Ambient Sensor

NCT03120741

Mild Cognitive Impairment, Dementia

UNKNOWN

Alzheimer Patients and the Snoezelen Program

NCT00548951

Dementia

COMPLETED PHASE1

Decreased Empathy and Emotion Recognition in Patients With Neurodegenerative Disease

NCT04635540

Neuro-Degenerative Disease Dementia Caregiver Burnout +4 more

UNKNOWN NA

Evaluation of Screening for Visual Disorders of the Old Subject in Consultation Memory

NCT02571647

Visual Disorders

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The secondary objectives of this study are to study the following elements in relationship to the implementation of a "Snoezelen-type" multi-sensory care strategy for patients with Alzheimer's-type neurodegenerative disease:

A. to evaluate the effects on NPI-Q scores at 1 month, 6 months and 12 months .

B. evaluate the effects on quality of life (questionnaire QOL-AD) at 0 and 12 months.

C. assess changes in the "aggressive behavior" subsection of the Cohen-Mansfield Agitation Inventory (CMAI) questionnaire over 0, 1, 3, 6 and 12 months.

D. assess changes in drug consumption (anxiolytics, antidepressants, hypnotics, neuroleptics)over the study period

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study population

Patients hospitalized at the Serre-Cavalier centre and who have Alzheimer's-type neurodegenerative disease (see inclusion criteria).

Group Type EXPERIMENTAL

Multi-sensory supportive care

Intervention Type OTHER

The Serre-Cavalier center will implement Snoezelen-type multisensory care sessions for included patients; these care sessions correspond with the patients' daily hygiene/toilette care.

The impact of this multisensory strategy will be evaluated using a before-after design.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Multi-sensory supportive care

The Serre-Cavalier center will implement Snoezelen-type multisensory care sessions for included patients; these care sessions correspond with the patients' daily hygiene/toilette care.

The impact of this multisensory strategy will be evaluated using a before-after design.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Snoezelen-type care Snoezelen toilette

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patient's legal representative must have given his/her informed and signed consent (or the patient if he/she is judged competent)
* The patient must be insured or beneficiary of a health insurance plan
* Alzheimer's-type neurodegenerative pathology
* The patient has been living in the participating center for \> 2 months

Exclusion Criteria

* The patient's legal representative refuses to sign the consent (or the patient if he/she is judged competent)
* It is impossible to correctly inform the patient's legal representative
* The patient has already has Snoezelen-therapy

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No